ARISTEIA CAPITAL, L.L.C. - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 2 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
ARISTEIA CAPITAL, L.L.C. ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$1,715
-89.9%
175,0000.0%0.00%–
Q3 2022$17,000
+30.8%
175,0000.0%0.00%–
Q2 2022$13,000
-59.4%
175,0000.0%0.00%
-100.0%
Q1 2022$32,000–175,000–0.00%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q1 2023
NameSharesValueWeighting ↓
Lynwood Capital Management Inc. 9,800$108,0540.10%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders